Diarrhea and Constipation Drug Development Pipeline Review, 2018
SKU ID :GBI-12161745 | Published Date: 30-Jul-2018 | No. of pages: 93Description
TOC
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Diarrhea and Constipation Report Coverage 7
2.2 Constipation - Overview 7
2.3 Diarrhea - Overview 7
3 Therapeutics Development 8
3.1 Constipation 8
3.2 Diarrhea 13
4 Therapeutics Assessment 20
4.1 Constipation 20
4.2 Diarrhea 26
5 Companies Involved in Therapeutics Development 33
5.1 Constipation 33
5.2 Diarrhea 41
6 Dormant Projects 57
6.1 Constipation 57
6.2 Diarrhea 58
7 Discontinued Products 61
7.1 Constipation 61
7.2 Diarrhea 61
8 Product Development Milestones 62
8.1 Constipation 62
8.2 Diarrhea 78
9 Appendix 92
9.1 Methodology 92
9.2 Coverage 92
9.3 Secondary Research 92
9.4 Primary Research 92
9.5 Expert Panel Validation 92
9.6 Contact Us 93
9.7 Disclaimer 93
Tables & Figures
1.1 List of Tables
Table 1: Number of Products under Development for Constipation 8
Table 2: Number of Products under Development by Companies, Constipation 10
Table 3: Number of Products under Development by Universities/Institutes, Constipation 11
Table 4: Products under Development by Companies, Constipation 12
Table 5: Products under Development by Universities/Institutes, Constipation 13
Table 6: Number of Products under Development for Diarrhea 13
Table 7: Number of Products under Development by Companies, Diarrhea 14
Table 8: Number of Products under Development by Universities/Institutes, Diarrhea 16
Table 9: Products under Development by Companies, Diarrhea 17
Table 10: Products under Development by Universities/Institutes, Diarrhea 19
Table 11: Number of Products by Stage and Target, Constipation 21
Table 12: Number of Products by Stage and Mechanism of Action, Constipation 22
Table 13: Number of Products by Stage and Route of Administration, Constipation 24
Table 14: Number of Products by Stage and Molecule Type, Constipation 25
Table 15: Number of Products by Stage and Target, Diarrhea 27
Table 16: Number of Products by Stage and Mechanism of Action, Diarrhea 29
Table 17: Number of Products by Stage and Route of Administration, Diarrhea 31
Table 18: Number of Products by Stage and Molecule Type, Diarrhea 32
Table 19: Constipation - Pipeline by Allergan Plc 33
Table 20: Constipation - Pipeline by Ardelyx Inc 33
Table 21: Constipation - Pipeline by Braintree Laboratories Inc 34
Table 22: Constipation - Pipeline by Dong-A ST Co Ltd 34
Table 23: Constipation - Pipeline by EA Pharma Co Ltd 35
Table 24: Constipation - Pipeline by Ironwood Pharmaceuticals Inc 35
Table 25: Constipation - Pipeline by Johnson & Johnson 36
Table 26: Constipation - Pipeline by MallInckrodt Plc 37
Table 27: Constipation - Pipeline by NGM Biopharmaceuticals Inc 37
Table 28: Constipation - Pipeline by RaQualia Pharma Inc 38
Table 29: Constipation - Pipeline by Sanwa Kagaku Kenkyusho Co Ltd 38
Table 30: Constipation - Pipeline by SK Biopharmaceuticals Co Ltd 38
Table 31: Constipation - Pipeline by Sumitomo Dainippon Pharma Co Ltd 39
Table 32: Constipation - Pipeline by Synthetic Biologics Inc 39
Table 33: Constipation - Pipeline by Vanda Pharmaceuticals Inc 40
Table 34: Constipation - Pipeline by Yuhan Corp 40
Table 35: Constipation - Pipeline by Zensun (Shanghai) Sci & Tech Co Ltd 41
Table 36: Diarrhea - Pipeline by Aegis Therapeutics LLC 41
Table 37: Diarrhea - Pipeline by Akthelia Pharmaceuticals Ltd 42
Table 38: Diarrhea - Pipeline by Albireo Pharma Inc 42
Table 39: Diarrhea - Pipeline by Allergan Plc 43
Table 40: Diarrhea - Pipeline by Ardelyx Inc 43
Table 41: Diarrhea - Pipeline by AzurRx BioPharma Inc 43
Table 42: Diarrhea - Pipeline by Bharat Biotech Ltd 44
Table 43: Diarrhea - Pipeline by Chongqing Zhifei Biological Products Co Ltd 44
Table 44: Diarrhea - Pipeline by Cosmo Pharmaceuticals NV 45
Table 45: Diarrhea - Pipeline by DiscoveryBiomed Inc 45
Table 46: Diarrhea - Pipeline by Ferring International Center SA 46
Table 47: Diarrhea - Pipeline by GP Pharm SA 46
Table 48: Diarrhea - Pipeline by Kuhnil Pharmaceutical Co Ltd 47
Table 49: Diarrhea - Pipeline by Metacrine Inc 47
Table 50: Diarrhea - Pipeline by Miyarisan Pharmaceutical Company Ltd 48
Table 51: Diarrhea - Pipeline by Napo Pharmaceuticals Inc 48
Table 52: Diarrhea - Pipeline by Nippon Shinyaku Co Ltd 49
Table 53: Diarrhea - Pipeline by Novartis AG 49
Table 54: Diarrhea - Pipeline by Pfizer Inc 50
Table 55: Diarrhea - Pipeline by Prokarium Ltd 50
Table 56: Diarrhea - Pipeline by Protagonist Therapeutics Inc 51
Table 57: Diarrhea - Pipeline by RaQualia Pharma Inc 51
Table 58: Diarrhea - Pipeline by RedHill Biopharma Ltd 52
Table 59: Diarrhea - Pipeline by RxBio Inc 52
Table 60: Diarrhea - Pipeline by Scandinavian Biopharma Holding AB 531.2 List of Figures
Figure 1: Number of Products under Development for Constipation 8
Figure 2: Number of Products under Development by Companies, Constipation 9
Figure 3: Number of Products under Development for Diarrhea 13
Figure 4: Number of Products under Development by Companies, Diarrhea 14
Figure 5: Number of Products under Development by Universities/Institutes, Diarrhea 16
Figure 6: Number of Products by Targets, Constipation 20
Figure 7: Number of Products by Stage and Targets, Constipation 20
Figure 8: Number of Products by Top 10 Mechanism of Actions, Constipation 21
Figure 9: Number of Products by Stage and Top 10 Mechanism of Actions, Constipation 22
Figure 10: Number of Products by Routes of Administration, Constipation 23
Figure 11: Number of Products by Stage and Routes of Administration, Constipation 23
Figure 12: Number of Products by Molecule Types, Constipation 24
Figure 13: Number of Products by Stage and Molecule Types, Constipation 25
Figure 14: Number of Products by Top 10 Targets, Diarrhea 26
Figure 15: Number of Products by Stage and Top 10 Targets, Diarrhea 26
Figure 16: Number of Products by Top 10 Mechanism of Actions, Diarrhea 28
Figure 17: Number of Products by Stage and Top 10 Mechanism of Actions, Diarrhea 28
Figure 18: Number of Products by Routes of Administration, Diarrhea 30
Figure 19: Number of Products by Stage and Routes of Administration, Diarrhea 30
Figure 20: Number of Products by Top 10 Molecule Types, Diarrhea 31
Figure 21: Number of Products by Stage and Top 10 Molecule Types, Diarrhea 32
Companies
Aegis Therapeutics LLC
Akthelia Pharmaceuticals Ltd
Albireo Pharma Inc
Allergan Plc
Ardelyx Inc
AzurRx BioPharma Inc
Bharat Biotech Ltd
Braintree Laboratories Inc
Chongqing Zhifei Biological Products Co Ltd
Cosmo Pharmaceuticals NV
Diarrhea
DiscoveryBiomed Inc
Dong-A ST Co Ltd
EA Pharma Co Ltd
Ferring International Center SA
GP Pharm SA
Ironwood Pharmaceuticals Inc
Johnson & Johnson
Kuhnil Pharmaceutical Co Ltd
MallInckrodt Plc
Metacrine Inc
Miyarisan Pharmaceutical Company Ltd
Napo Pharmaceuticals Inc
NGM Biopharmaceuticals Inc
Nippon Shinyaku Co Ltd
Novartis AG
Pfizer Inc
Prokarium Ltd
Protagonist Therapeutics Inc
RaQualia Pharma Inc
RedHill Biopharma Ltd
RxBio Inc
Sanwa Kagaku Kenkyusho Co Ltd
Scandinavian Biopharma Holding AB
SK Biopharmaceuticals Co Ltd
Sublimity Therapeutics Ltd
Sumitomo Dainippon Pharma Co Ltd
Summit Therapeutics Plc
Synthetic Biologics Inc
Syntiron LLC
Tasly Pharmaceutical Group Co Ltd
Vanda Pharmaceuticals Inc
Wuhan Institute of Biological Products Co Ltd
Yuhan Corp
Zealand Pharma AS
Zensun (Shanghai) Sci & Tech Co Ltd
- PRICE
-
$3995$11985